Technology | April 16, 2012

Elekta Unveils New Neuroscience Solution for Leksell Gamma Knife at AANS

Elekta Unveils New Neuroscience Solution for Leksell Gamma Knife at AANS

April 16, 2012 — Elekta is revealing innovations for Leksell Gamma Knife Perfexion this week at the 2012 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Miami.

"Once again, AANS will give us the opportunity to demonstrate to neurological surgeons that Gamma Knife radiosurgery is a continually evolving technique," says Jay Hoey, executive vice president, Elekta North America. "The latest example is the capability to exchange information, such as treatment plans, treatment record and protocols, both pre- and post-treatment, putting electronic medical records at your fingertips and allowing you to see all of your treatment statistics in one convenient dashboard. The result is a better flow of patient care and improved use of time and resources."

In addition to the latest product enhancements, Elekta will highlight characteristics of Leksell Gamma Knife Perfexion, including its dedication to intracranial cases, complete solution integration, "shrink-wrap" dose conformity and proven clinical efficacy. Demonstrations of the system will emphasize that Perfexion is designed to minimize risk of human error and radiation toxicity, while optimizing accuracy and dose conformance.

At the meeting Elekta is also exhibiting several other solutions that improve the management of neurological and neurosurgical cases, including:

  • Extend System for frameless, multi-session hypofractionation Gamma Knife radiosurgery;
  • Elekta Neuromag Triux magnetoencephalography (MEG) system;
  • Leksell Stereotactic System for functional neurosurgery; and
  • Leksell SurgiPlan 10, Elekta's image-based neurosurgical planning software specifically designed for the Leksell Stereotactic System.

 

For more information: www.elekta.com

Related Content

New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at
Improved Imaging for Prostate Cancer Could Lead to More Effective Treatment

The picture shows that time series signal is extracted from a series of ultrasound frames for classification. Each patch across a number of frames inside the prostate is classified into either cancerous or normal tissue. The image at the lower right corner shows the overall result for those frames. Image courtesy of Pingkun Yan and researchers from NIH, University of British Columbia and Queens University.

News | Ultrasound Imaging | May 28, 2019
Engineers at Rensselaer Polytechnic Institute are working to improve imaging methods in order to make medicine more...